Clinical Trials on Relapsed Ovarian Cancer
Total 95366 results
-
Georgetown UniversityNational Cancer Institute (NCI); National Human Genome Research Institute (NHGRI)CompletedBreast Cancer | Hereditary Breast/Ovarian Cancer (brca1, brca2)United States
-
NCIC Clinical Trials GroupEuropean Organisation for Research and Treatment of Cancer - EORTC; Grupo Español...CompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity CancerCanada
-
Genentech, Inc.CompletedOvarian Cancer, Pancreatic CancerUnited States
-
Queensland Centre for Gynaecological CancerThe University of Queensland; Cancer Australia Priority-driven Collaborative...CompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal CancerAustralia
-
AstraZenecaCompletedAdvanced Ovarian Cancer | Paclitaxel | Carboplatin | Triple Negative Metastatic Breast CancerBelgium, Netherlands, United Kingdom
-
Aduro Biotech, Inc.Incyte CorporationTerminatedPlatinum-resistant Ovarian Cancer | Platinum-resistant Fallopian Cancer | Platinum-resistant Peritoneal CancerUnited States, Canada
-
SOTIO a.s.CompletedOvarian Neoplasms | Ovarian Epithelial CancerCzechia, Poland
-
Grupo Español de Investigación en Cáncer de OvarioRoche Pharma AGTerminated
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedPain | Neuropathy | Stage IIIA Fallopian Tube Cancer | Stage IIIA Ovarian Cancer | Stage IIIA Primary Peritoneal Cancer | Stage IIIB Fallopian Tube Cancer | Stage IIIB Ovarian Cancer | Stage IIIB Primary Peritoneal Cancer | Stage IIIC Fallopian Tube Cancer | Stage IIIC Ovarian Cancer | Stage IIIC Primary... and other conditionsUnited States
-
AstraZenecaRecruitingER+ HER2- Advanced Breast Cancer | High-grade Serous Ovarian Cancer (HGSOC)United States, United Kingdom, Korea, Republic of, Australia, Spain
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedPrimary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial CancerUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Cancer | Primary Peritoneal Cavity CancerUnited States, Canada
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage IV Ovarian Epithelial Cancer | Stage IV Ovarian Germ Cell Tumor | Stage III Ovarian Epithelial Cancer | Stage III Ovarian Germ Cell TumorUnited States
-
University of MiamiWithdrawnOvarian Cancer | Recurrent Ovarian Carcinoma | Ovarian Carcinoma | Recurrent Ovarian Cancer
-
Ling-Ying WuNot yet recruiting
-
AGO Research GmbHRecruitingEpithelial Ovarian CancerGermany
-
Groupe Hospitalier Diaconesses Croix Saint-SimonGERCOR - Multidisciplinary Oncology Cooperative GroupRecruitingOvarian Cancer, EpithelialFrance
-
Grupo Español de Investigación en Cáncer de OvarioAstraZenecaCompletedAdvanced Ovarian CancerSpain
-
Opna-IO LLCTerminatedEpithelial Ovarian Cancer | Gynecologic NeoplasmsUnited States, Canada
-
Shanghai East HospitalAnhui Provincial Hospital; Nanjing Legend Biotech Co.; East Clinical Center of...Terminated
-
Translational Research in OncologyCelgeneTerminatedEpithelial Ovarian CancerUnited States
-
Jun ZhangCompletedAdvanced Ovarian CancerChina
-
Institut du Cancer de Montpellier - Val d'AurelleCompletedMetastatic Ovarian CancerFrance
-
RenJi HospitalCompletedEpithelial Ovarian CancerChina
-
Merck Sharp & Dohme LLCCompleted
-
Asan Medical CenterSanofiCompletedAdvanced Ovarian CancerKorea, Republic of
-
Prima BioMed LtdCompleted
-
Grupo Español de Investigación en Cáncer de OvarioCompletedPlatinum-resistant Advanced Ovarian CancerSpain
-
ARCAGY/ GINECO GROUPRoche Pharma AGCompleted
-
Translational Research in OncologyTerminatedOvarian NeoplasmsUnited States, France, Germany, Israel, Ireland, Spain, Canada, United Kingdom
-
MorphotekCompletedEpithelial Ovarian CancerUnited States
-
Russian Academy of Medical SciencesUnknownOvarian CancerRussian Federation
-
Cancer Research UKCompletedOvarian CancerUnited Kingdom
-
Alexandria UniversityRecruitingOvarian Epithelial CancerEgypt
-
MTrap, Inc.MedPass InternationalCompletedOvarian Cancer Stage IIIC | Ovarian Cancer Stage IVSpain
-
Azaya Therapeutics, Inc.UnknownCancer | Ovarian Cancer | Ovarian Epithelial Cancer Recurrent | Malignant Female Reproductive System Neoplasm | Ovarian TumorCanada, United States
-
National Cancer Institute (NCI)CompletedStage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Stage IV Endometrial Carcinoma | Stage I Ovarian Epithelial Cancer | Stage II Ovarian Epithelial Cancer | Stage III Ovarian Epithelial Cancer | Stage IA Cervical Cancer | Stage IB Cervical Cancer | Stage IIA Cervical Cancer | Stage... and other conditionsUnited States
-
Sinai Hospital of BaltimoreUnknownOvarian Cancer | Endometrial CancerUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Cancer | Primary Peritoneal Cavity CancerUnited States, Norway
-
National Cancer Institute (NCI)CompletedPrimary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial CancerUnited States
-
Mersana TherapeuticsIQVIA Biotech; PSI CRORecruitingPlatinum Resistant Ovarian Cancer | Non Small Cell Lung Cancer MetastaticUnited States, Spain, United Kingdom, Australia, France, Austria, Belgium, Bulgaria, Canada, Czechia, Denmark, Finland, Hungary, Italy, Lithuania, New Zealand, Norway, Poland, Sweden
-
University of OklahomaVerastem, Inc.RecruitingCervical Cancer | Solid Tumor | Endometrioid Cancer | Mucinous Ovarian Cancer | High Grade Serous Ovarian CancerUnited States
-
Seoul National University HospitalRecruitingFallopian Tube Cancer | Peritoneal Cancer | Ovarian Cancer Stage IIIC | Ovarian Cancer Stage IVKorea, Republic of
-
AbbVieCompletedOncology | High Grade Serous Ovarian Cancer | BRCA Mutated | BRCA Mutated Breast Cancer
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruiting
-
Jiangxi Qingfeng Pharmaceutical Co. Ltd.RecruitingAdvanced Ovarian CancerChina
-
Japanese Gynecologic Oncology GroupKorean Gynecologic Oncology GroupRecruitingEpithelial Ovarian CancerJapan, Korea, Republic of
-
Women's Hospital School Of Medicine Zhejiang UniversityActive, not recruiting
-
Baylor Research InstituteActive, not recruitingEpithelial Ovarian CancerUnited States
-
MorphotekTerminatedEpithelial Ovarian CancerUnited States, Germany